0001127602-21-018362.txt : 20210528
0001127602-21-018362.hdr.sgml : 20210528
20210528193940
ACCESSION NUMBER: 0001127602-21-018362
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210526
FILED AS OF DATE: 20210528
DATE AS OF CHANGE: 20210528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Whelan, Jr. Robert M.
CENTRAL INDEX KEY: 0001490045
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34630
FILM NUMBER: 21982370
MAIL ADDRESS:
STREET 1: ARIAD PHARMACEUTICALS, INC.
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASPEN TECHNOLOGY INC /DE/
CENTRAL INDEX KEY: 0000929940
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
IRS NUMBER: 042739697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 20 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-221-4302
MAIL ADDRESS:
STREET 1: 20 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-05-26
0000929940
ASPEN TECHNOLOGY INC /DE/
AZPN
0001490045
Whelan, Jr. Robert M.
C/O ASPEN TECHNOLOGY, INC.
20 CROSBY DRIVE
BEDFORD
MA
01730
1
Common Stock
2021-05-26
4
M
0
6048
15.50
A
17759
D
Common Stock
2021-05-26
4
M
0
1444
133.20
A
19203
D
Common Stock
2021-05-26
4
M
0
1474
130.51
A
20677
D
Common Stock
2021-05-26
4
S
0
370
138.92
D
11341
D
Common Stock
2021-05-26
4
S
0
5089
139.49
D
6252
D
Common Stock
2021-05-26
4
S
0
3255
140.46
D
2997
D
Common Stock
2021-05-26
4
S
0
252
141.06
D
2745
D
Common Stock Option (Right to Buy)
15.50
2021-05-26
4
M
0
6048
0
D
2021-07-31
Common Stock
6048
0
D
Director Stock Option (Right to Buy)
133.20
2021-05-26
4
M
0
1444
0
D
2019-09-03
2029-09-02
Common Stock
1444
0
D
Director Stock Option (Right to Buy)
130.51
2021-05-26
4
M
0
1474
0
D
2020-12-28
2030-12-27
Common Stock
1474
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.86 to $138.96; $139.01 to $ 139.99; $140.01 to $140.98; and $141.05 to $141.09 , inclusive. The reporting person undertakes to provide to Aspen Technology, Inc., any security holder of Aspen Technology, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the applicable range set forth in this footnote.
The option granted at the exercise price of $15.50 was fully vested on the date of grant.
The option granted at the exercise price of $133.20 was fully vested on the date of grant.
The option granted at the exercise price of $130.51 was fully vested on the date of grant.
/s/ F.G. Hammond, attorney-in-fact for Mr. Whelan
2021-05-28